ENXTPA:EAPIPharmaceuticals
Euroapi (ENXTPA:EAPI) Losses On €852.6 Million TTM Revenue Test Margin Recovery Narrative
Euroapi (ENXTPA:EAPI) has posted its latest full year 2025 numbers with first half revenue of €414.5 million and a basic EPS loss of €0.30, while trailing twelve month revenue sits at €852.6 million against a net income loss of €211.2 million. Over recent periods the company has seen revenue move from €450.9 million in the first half of 2024 to €468.3 million in the second half of 2024 and then to €414.5 million in the first half of 2025. This has come alongside basic EPS losses of €0.37,...